TY  - BOOK
AU  - Sloan,Frank A.
AU  - Hsieh,Chee-Ruey
TI  - Pharmaceutical innovation: incentives, competition, and cost-benefit analysis in international perspective 
SN  - 0521874904 (hardback)
PY  - 2007///
CY  - Cambridge, New York
PB  - Cambridge University Press
KW  - Drug Industry
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Economic Competition
KW  - Health policy
KW  - Pharmaceutical Preparations
KW  - Vaccines
N1  - Includes bibliographical references (p. 293-317) and index; Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh
ER  -